CareDx, Inc. CDNA
Analyst Ratings
- Consensus
- Moderate Buy — 2 Buy · 2 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $48.00 (-11.6% downside)
Key Stats
- Today's Range
- $53.21 – $55.16
- 50-Day Range
- $27.68 – $55.16
- 52-Week Range
- $11.27 – $55.16
- Volume
- 807K shs
- Average Volume
- 1.05 million shs
- Market Cap
- $2.81 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 7.55%
- Days to Cover
- 20.17
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Related Stocks
Compare head-to-head: CDNA vs NTRA·CDNA vs DGX·CDNA vs CAI·CDNA vs BLLN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.